default author photo

Seina Honda

Jichi Medical University - Division of Hematology

SCHOLARLY PAPERS

1

DOWNLOADS

57

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Cost-Effectiveness of Blinatumomab as a Post-Remission Therapy for MRD-Negative, Ph-Negative Adult B-ALL Patients

Number of pages: 37 Posted: 22 Aug 2025
Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology and Jichi Medical University - Division of Hematology
Downloads 57 (1,000,027)

Abstract:

Loading...

blinatumomab, acute lymphoblastic leukemia, Philadelphia-chromosome negative, cost-effectiveness analysis